Bayer drug doubles kidney failure risk: study
Posted on: Wednesday, 25 January 2006, 17:02 CST
BOSTON (Reuters) - The Bayer drug Trasylol, widely given to heart surgery patients to prevent excessive blood loss, doubles the risk of kidney failure and stroke, researchers reported on Wednesday.
It also raises the chance of heart failure or heart attack by 55 percent, according to the study published in this week's New England Journal of Medicine.
Source: REUTERS
Related Articles
- A Super Pill to Thwart Heart Attacks and Stroke?
- Adult Stem Cells Show Promise for Heart Failure
- Blood Treatment Targets Heart Disease
- Caffeine and Ephedra Before Workout Tax Heart
- Aspirin Resistance Increases Heart Attack and Stroke Risk
- Blood Protein Tied to Heart Failure
- Beating Odds of Heart Disease, Stroke in Diabetics
- Activity and exercise for heart failure
- A Better Way To Measure Heart Damage
- Bypass Surgery Can Bypass Heart-Lung Pump
Rating: 3.1 / 5 (10 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds